Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OnabotulinumtoxinA in the Management of Psychogenic Dystonia

NCT02618889 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02618889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Completed
Start date
January 15, 2016
Completion date
June 30, 2017
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

torticollis, dystonia